B. Braun Spinal Anesthesia Kit Injury Lawsuit Lawyers

FDA Class I Recall Issued After Contaminated Bupivacaine in Certain B. Braun Convenience Kits Is Linked to Serious Injuries and Potential Life-Threatening Complications

What Parker Waichman LLP Found:

• The FDA issued a Class I recall for certain B. Braun spinal anesthesia kits containing recalled Huons bupivacaine.
• The affected kits may expose patients to serious infections and life-threatening neurological complications.
• Healthcare providers have been instructed to stop using, quarantine, and return the recalled products.
• As of April 24, 2026, there have been 35 serious injuries had been reported in connection with the recall.

The U.S. Food and Drug Administration (FDA) has identified a recall involving certain B. Braun Medical, Inc. spinal anesthesia convenience kits as a Class I recall, the agency’s most serious recall classification. A Class I recall is issued when there is a reasonable probability that continued use of a medical device or product could cause serious injuries or death.

The recall affects several B. Braun spinal anesthesia procedure kits that contain Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, a medication commonly administered during spinal anesthesia and regional pain management procedures. According to the FDA, Huons Co., Ltd. previously recalled the injectable anesthetic, prompting B. Braun to remove affected convenience kits from hospitals and healthcare facilities throughout the United States.

Healthcare providers have been instructed to immediately stop using the affected products, quarantine remaining inventory, and return recalled kits to the manufacturer. Hospitals and medical facilities that distributed the products to other locations have also been instructed to notify those facilities so the recall reaches every level where the devices may be in use.

This recall is particularly concerning because spinal anesthesia places medication directly into or near the central nervous system. If contamination occurs or the medication fails to perform as intended, patients may face severe neurological complications that require emergency treatment.

As of April 24, B. Braun reported 35 serious injuries associated with this recall. Although no deaths had been reported at the time of the FDA announcement, the injuries described by regulators demonstrate the significant risks that may result when compromised injectable medications are used during spinal procedures.

Which B. Braun Products Are Included in the Recall?

The recall applies to several B. Braun spinal anesthesia procedure kits that contain the affected Huons Bupivacaine Hydrochloride in Dextrose Injection, USP.

Affected products include:

• B. Braun PENCAN Spinal Needle Procedure Kits
• B. Braun Spinocan Spinal Needle Procedure Kits
• B. Braun Spinocan Spinal Tray Spinal Needle Anesthesia Procedure Kits

These products are commonly packaged as convenience kits used during surgical procedures requiring spinal anesthesia or regional pain control. Rather than gathering each individual component separately, healthcare providers use these kits because they contain multiple sterile medical products assembled together for efficiency.

Although the kits themselves contain several medical devices, the recall centers on the injectable anesthetic contained within the kits.

Because these products were supplied directly to hospitals and healthcare facilities, many patients may never know which specific spinal anesthesia products were used during their procedures unless their medical records are reviewed.

Why This FDA Recall Is Classified as Class I

The FDA reserves Class I recalls for situations involving products that present the greatest potential danger to patients.

Unlike recalls involving labeling errors or minor packaging defects, Class I recalls generally involve products capable of causing permanent injuries, severe illness, or death.

In this case, regulators warned that compromised injectable anesthetic products may create multiple life-threatening complications, including:

• Serious infections
• Inflammatory reactions
• Reduced anesthetic effectiveness
• Cerebrospinal fluid contamination
• Meningitis
• Encephalitis
• Emergency conversion from spinal anesthesia to general anesthesia

These risks become particularly significant because spinal anesthesia requires medication to be administered directly into the neuraxial space surrounding the spinal cord. Any contamination introduced into this highly sensitive area can spread rapidly throughout the central nervous system.

Patients receiving spinal anesthesia often undergo orthopedic surgery, cesarean deliveries, urologic procedures, vascular surgery, and numerous other operations where maintaining a sterile environment is absolutely critical.

Understanding the Risks Associated With Contaminated Injectable Medications

Injectable medications undergo strict manufacturing and sterility requirements because they bypass many of the body’s natural defenses against infection.

When contamination occurs during manufacturing, packaging, or distribution, harmful microorganisms or foreign substances may enter the patient’s body directly.

According to the FDA, the recalled Huons Bupivacaine Hydrochloride in Dextrose Injection, USP may expose patients to several serious medical complications.

Infection

A contaminated injectable medication may introduce bacteria or other pathogens into sterile areas of the body. Once infection develops, patients may require hospitalization, intravenous antibiotics, additional surgeries, or prolonged medical treatment.

Inflammatory Responses

Some compromised injectable products can trigger severe inflammatory reactions even without active infection. Inflammation involving tissues surrounding the spinal cord may produce significant pain, swelling, nerve irritation, and neurological symptoms.

Reduced Anesthetic Effectiveness

If spinal anesthesia does not work properly, patients may experience inadequate pain control during surgical procedures.

In certain situations, physicians may have no choice but to rapidly convert the patient from spinal anesthesia to general anesthesia while surgery is underway. Emergency changes in anesthesia can increase procedural complexity and expose patients to additional medical risks.

Cerebrospinal Fluid Contamination

Perhaps the most concerning risk identified by regulators involves contamination of cerebrospinal fluid.

Cerebrospinal fluid surrounds the brain and spinal cord. Any contamination entering this space may spread rapidly throughout the central nervous system. This type of complication requires immediate medical attention.

Meningitis and Encephalitis Can Become Medical Emergencies

Among the most serious complications identified in the FDA recall are meningitis and encephalitis.

Meningitis is an infection or inflammation affecting the protective membranes surrounding the brain and spinal cord.

Common symptoms may include:

• Severe headache
• Neck stiffness
• Fever
• Confusion
• Nausea
• Vomiting
• Sensitivity to light
• Altered mental status

Without prompt treatment, meningitis may progress rapidly and result in permanent neurological injury.

The FDA also warned about encephalitis, which involves inflammation of the brain itself.

Encephalitis may produce:

• Seizures
• Memory problems
• Difficulty speaking
• Weakness
• Loss of coordination
• Personality changes
• Permanent neurological impairment
• Coma

Both conditions require immediate diagnosis and aggressive medical treatment.

Even patients who survive these illnesses may experience long-term cognitive deficits, chronic pain, mobility limitations, or other permanent disabilities.

How Convenience Kits Are Used During Surgical Procedures

Convenience kits play an important role in modern operating rooms.

These kits contain multiple sterile medical products assembled into one package for use during specific medical procedures.

Spinal anesthesia kits generally include products necessary to perform regional anesthesia safely and efficiently.

Healthcare providers rely on these kits because they:

• Improve procedural efficiency
• Maintain sterile conditions
• Reduce preparation time
• Standardize equipment selection
• Minimize missing components during surgery.

When one component of a convenience kit becomes unsafe, however, every affected kit must generally be removed from circulation because healthcare providers cannot safely use the compromised medication.

Patients May Not Learn About Exposure Until After Surgery

One challenge involving medical device recalls is that patients often have no idea which medical products were used during their procedures.

Unlike consumer products purchased directly by individuals, hospital patients generally do not choose the specific spinal needle kit or injectable anesthetic used during surgery.

Patients who underwent spinal anesthesia during the affected time period may only discover their potential exposure after hospitals review inventory records or notify patients about the recall.

Individuals who experienced unexpected infections, meningitis, prolonged hospitalization, neurological symptoms, or additional surgeries after spinal anesthesia may wish to determine whether recalled products were involved in their care.

Medical records often contain lot numbers, product identification information, and documentation identifying the anesthesia products used during surgery.

Understanding Product Liability and Medical Device Lawsuits

Manufacturers of medical devices and injectable medications have a legal responsibility to produce products that are reasonably safe when used as intended.

When contaminated medications or defective medical products cause injuries, affected patients may have legal rights under product liability laws.

Depending on the circumstances, investigations may examine whether injuries resulted from:

• Manufacturing defects
• Sterility failures
• Contamination during production
• Quality control failures
• Inadequate testing
• Failure to identify manufacturing problems
• Failure to warn healthcare providers promptly

A product liability investigation may involve reviewing FDA inspection records, manufacturing documentation, adverse event reports, internal company communications, laboratory testing, and medical evidence linking patient injuries to recalled products.

Compensation Available in Medical Device Recall Cases

Patients harmed by contaminated injectable medications may experience extensive financial, physical, and emotional losses.

Depending on the circumstances, compensation may include:

• Past medical expenses
• Future medical treatment
• Hospitalization costs
• Rehabilitation expenses
• Lost wages
• Reduced earning capacity
• Pain and suffering
• Emotional distress
• Permanent disability
• Long-term neurological care

Each claim depends on the patient’s specific injuries, medical history, treatment records, and evidence connecting the recalled product to the resulting complications.

B. Braun Spinal Anesthesia Kit Injury Lawsuit FAQs

Can I file a lawsuit if I became seriously ill after receiving spinal anesthesia?

Possibly. Patients who developed infections, meningitis, neurological injuries, or other complications after receiving spinal anesthesia may have legal claims if a recalled product contributed to their injuries. A thorough review of medical records is often necessary to determine whether an affected B. Braun convenience kit or recalled injectable medication was used during the procedure.

What types of injuries have been associated with this recall?

According to the FDA, potential complications include infection, inflammatory reactions, reduced anesthetic effectiveness, contamination of cerebrospinal fluid, meningitis, encephalitis, and the need to convert unexpectedly to general anesthesia during surgery. Some of these complications may require emergency treatment and may lead to long-term neurological damage.

Does an FDA Class I recall mean the product was dangerous?

A Class I recall is the FDA’s most serious recall category. It indicates that continued use of the product presents a reasonable probability of causing serious injury or death. Although each patient’s circumstances are unique, a Class I recall reflects significant safety concerns that warrant immediate action by healthcare providers.

What compensation may be available in a recalled medical device case?

Patients may be entitled to recover compensation for medical expenses, future healthcare costs, rehabilitation, lost income, diminished earning capacity, pain and suffering, emotional distress, and other losses resulting from their injuries. The amount of compensation depends on the severity of the injuries and the facts of each case.

How can I find out whether a recalled product was used during my surgery?

Your medical records may identify the spinal anesthesia kit, medication lot number, and other products used during your procedure. Hospitals often maintain detailed documentation regarding medical devices and medications administered during surgery. An attorney can also help obtain and review these records when investigating a potential claim.

What evidence is important in a medical device lawsuit?

Medical records, operative reports, pharmacy records, hospital documentation, imaging studies, laboratory results, follow-up treatment records, and expert medical opinions may all play important roles in establishing whether a recalled product contributed to a patient’s injuries.

Is there a deadline to file a lawsuit?

Yes. Product liability claims are subject to statutes of limitations that vary by state. Missing the applicable filing deadline can prevent an injured patient from pursuing compensation. Because these deadlines differ depending on the jurisdiction and circumstances, it is important to evaluate potential claims promptly.

Contact Parker Waichman LLP for a Free Consultation About the B. Braun Spinal Anesthesia Kit Recall

Patients trust hospitals and medical device manufacturers to provide sterile, safe products during surgery. When recalled spinal anesthesia products allegedly contribute to serious infections, neurological injuries, or other life-threatening complications, patients and their families deserve answers.

Parker Waichman LLP represents individuals nationwide in product liability litigation involving defective medical devices, recalled pharmaceutical products, and dangerous medical equipment. If you or a loved one experienced serious complications after receiving spinal anesthesia, you may have important legal rights.

Parker Waichman LLP offers free consultations to help injured patients understand their legal options. Call 1-800-YOUR-LAWYER (1-800-968-7529) today to discuss your potential claim. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.